• Share the latest HS management techniques
  • Create HS research opportunities and education for Canadian Dermatologists and mentorship for residents
  • Establish cross-specialty dialogue to improve HS patient outcomes
  • Collaborate with international HS foundations to optimize research, education and patient care
a guide to living with hs provided by the canadian hidradenitis suppurativa foundation.

Diagnosed with HS?

A Guide to Hidradentitis Suppurativa: Living with HS aims to help individuals with Hidradenitis Suppurativa (HS) to learn more about HS and how to effectively manage this condition. In conjunction with patients, this book is suitable for family members and friends of HS patients, as well as generalist healthcare practitioners who would like to increase their understanding of HS and the challenges associated with this condition.

shsa 2024 scaled

Note: Deadline for application as of September 24, 2024

 

The Canadian Hidradenitis Suppurativa Foundation (CHSF) is offering travel grants for Canadian dermatology residents to attend the HS Academy from December 6-8, 2024, in Irving, Texas. Four grants are available, providing up to $1,250 in reimbursement. 

The application deadline is October 23, 2024.

hsacademy1
a close up of a pink and purple tissue, supporting the canadian hidradenitis suppurativa foundation.

What Is Hidradenitis Suppurativa (HS)?

Hidradenitis suppurativa (HS) is a painful, long-term skin condition that causes abscesses and scarring on the skin. The exact cause of hidradenitis suppurativa is unknown, but it occurs near hair follicles where there are sweat glands, usually around the groin, bottom, breasts and armpits.

THE PAIN IS TO THE CORE, TO THE POINT WHERE IT IS DEBILITATING. AS A RESULT, I LEARNT TO LANCE MY LESIONS.
WE REALLY NEED MORE DISEASE AWARENESS AND SUPPORT.

Joshua
A PERSON LIVING WITH HS, SHARED

PAST EVENTS

Higher Standards for Hidradenitis Suppurativa Deroofing Program

We couldn’t be prouder of the first certified dermatologists of the Canadian Hidradenitis Suppurativa Foundation’s national Higher Standards for Hidradenitis Suppurativa Deroofing Program! 

Dr. Chris Keeling and Dr. Lauren Lam led a weekend hands-on workshop for dermatologists and nurses from all across Canada, including Prince George, Kelowna, Kamloops, Red Deer, London,  Toronto, and Scarborough!

The goal of the CHSF was to provide a standardized training program for dermatologists to become confident enough to incorporate deroofing in their own practices so that our rural patients no longer need to drive 6 hours to see us for deroofing.

It also allows patients & referring doctors to be confident that the dermatologist they are being referred to has had certified training!

We will be revisiting the group periodically to see how much progress we are making year by year in growing the community of deroofing dermatologists, so stay tuned!

Thank you to our sponsors!
 AmgenBeiersdorfBoehringer Ingelheim, Celltrion IncJAMP Pharma Group, NanoTessNovartis, Paladin Pharma, Pfizer, SanofiUCB


Instagram

Events & Supporters
novartis logo
celltrionhealthcare ci logo
pfizer logo
ucb logo
boehringeringelheim logo
beiersdorf logo
biojamp logo
amgen logo

Members

Executive Committee:

Helene Veillette – President (Quebec),  Lauren Lam – Vice-President (Alberta), Chris Keeling (Alberta) – Secretary/Treasurer, Susan Poelman – Past President (Alberta)

Board Members:
Ms. Pat Coutts (Ontario),  Ralph George (Ontario), Danielle Marcoux (Quebec), Simon Wong (British Columbia), Dr. Helene Veillette (Quebec), Rochelle Tonkin (Alberta), Raed Alhusayen (Ontario), Marni Wiseman (Manitoba), Jessica Asgarpour (Ontario)
Should you have any general health concerns or specific dermatological issues, we highly recommend that you first consult with your General Practitioner (GP) and obtain a referral to a dermatologist as needed. However, if you are specifically interested in participating in the INCYTE Clinical Research Study, please feel free to contact me directly for more information and guidance on this particular opportunity.